United Orthopedic Corporation (4129.TWO)
Taipei Exchange · TWD · Healthcare · Medical Devices
NT$77.20 (-0.90%) as of
Key statistics
- Market cap
- 7.45B
- P/E (TTM)
- 13.91
- Forward P/E
- 10.93
- EPS (TTM)
- 5.55
- Dividend yield
- 5.84%
- 52-week range
- 75.30 – 131.50
- Beta
- 0.41
- Revenue (TTM)
- 6.07B
- Profit margin
- 9.09%
- Analyst target
- NT$114.75
- Volume
- 76.45k
About United Orthopedic Corporation
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, rest of Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; spinal products comprising vertebral fixation devices; injury and other orthopedic products that consist of orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws and products; and OEM products, such as orthopedic internal fixation. It also provides its manufacturing equipment, as well as special metal and plastic materials. The company was incorporated in 1993 and is headquartered in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- New Taipei City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.